Before being appointed Chief Executive Officer in April 2018, Philip worked with NEPIC for 6 years helping deliver ERDF projects, and serving its pharmaceutical members. Prior to his time with the Cluster, Philip held roles at the Centre of Excellence in Life Sciences and technical management positions within GSK in the UK and US.   With extensive pharmaceutical process development and manufacturing experience in the fields of antibiotics and biopharmaceuticals, Philip holds a first degree in Biochemistry, a masters in Biochemical Engineering and is a member of the Institution of Chemical Engineers.